US Stock MarketDetailed Quotes
ACST Acasti Pharma
- 2.4500
- +0.0499+2.08%
Close Aug 23 16:00 ET
- 2.4500
- 0.00000.00%
Post 20:01 ET
24.84MMarket Cap-2333P/E (TTM)
2.5000High2.4000Low8.48KVolume2.4400Open2.4001Pre Close20.62KTurnover0.18%Turnover RatioLossP/E (Static)10.14MShares3.590052wk High0.42P/B11.38MFloat Cap1.720052wk Low--Dividend TTM4.65MShs Float2016.0000Historical High--Div YieldTTM4.17%Amplitude1.7200Historical Low2.4300Avg Price1Lot Size
Acasti Pharma Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 67.16%4.96M | -37.70%11.37M | -21.66%3.26M | -28.32%3.04M | -59.04%2.09M | -37.23%2.97M | 18.95%18.25M | -5.41%4.17M | 0.47%4.25M | 43.20%5.11M |
| Selling and administrative expenses | 20.47%2.25M | -19.09%6.64M | -38.67%1.54M | -9.86%1.6M | -10.78%1.63M | -10.65%1.87M | -16.04%8.21M | 21.14%2.52M | -13.25%1.78M | -38.70%1.83M |
| -Selling and marketing expense | ---- | 42.65%194K | 19.61%61K | -58.33%30K | 1,333.33%43K | ---- | 17.24%136K | 34.21%51K | -7.69%72K | --3K |
| -General and administrative expense | 20.47%2.25M | -20.13%6.45M | -39.88%1.48M | -7.81%1.57M | -12.99%1.59M | -10.22%1.87M | -16.44%8.08M | 20.89%2.47M | -13.47%1.7M | -38.80%1.83M |
| Research and development costs | 147.31%2.71M | -53.04%4.68M | 2.74%1.69M | -41.10%1.44M | -86.03%460K | -57.72%1.1M | 79.38%9.97M | -29.49%1.64M | 12.44%2.45M | 462.74%3.29M |
| Depreciation amortization depletion | -66.67%1K | -36.51%40K | 288.89%35K | ---- | 108.33%1K | -93.48%3K | --63K | --9K | --20K | ---12K |
| -Depreciation and amortization | -66.67%1K | -36.51%40K | 288.89%35K | ---- | 108.33%1K | -93.48%3K | --63K | --9K | --20K | ---12K |
| Operating profit | -67.16%-4.96M | 37.70%-11.37M | 21.66%-3.26M | 28.32%-3.04M | 59.04%-2.09M | 37.23%-2.97M | -18.95%-18.25M | 5.41%-4.17M | -0.47%-4.25M | -43.20%-5.11M |
| Net non-operating interest income expense | 75.37%235K | 270.33%911K | 122.32%249K | 371.64%316K | 488.89%212K | 318.75%134K | 219.48%246K | 198.25%112K | 67.50%67K | 157.14%36K |
| Non-operating interest income | 75.37%235K | 270.33%911K | 122.32%249K | 371.64%316K | 488.89%212K | 318.75%134K | 219.48%246K | 198.25%112K | 67.50%67K | 157.14%36K |
| Other net income (expense) | 193.91%1.39M | 87.55%-4.23M | 96.93%-1.04M | 753.33%128K | -15,225.00%-1.84M | -2,072.06%-1.48M | -808.30%-33.97M | -96,771.43%-33.91M | -96.31%15K | -100.26%-12K |
| Gain on sale of security | 17,237.50%1.39M | -4,325.81%-2.74M | -34,800.00%-1.04M | 753.33%128K | -15,225.00%-1.84M | 111.76%8K | -101.27%-62K | 101.65%3K | -97.71%15K | -100.26%-12K |
| Special income (charges) | --0 | 95.62%-1.49M | --0 | --0 | --0 | ---1.49M | -13,517.67%-33.91M | ---33.91M | --0 | --0 |
| -Less：Restructuring and merger&acquisition | --0 | --1.49M | --0 | --0 | --0 | --1.49M | --0 | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | --33.51M | ---- | ---- | ---- |
| -Write off | ---- | --0 | ---- | ---- | ---- | ---- | 60.64%400K | ---- | ---- | ---- |
| Income before tax | 22.52%-3.34M | 71.74%-14.69M | 89.32%-4.06M | 37.57%-2.6M | 26.85%-3.72M | 9.53%-4.31M | -396.52%-51.97M | -733.88%-37.96M | -10.19%-4.16M | -618.25%-5.08M |
| Income tax | -150.52%-724K | 80.80%-1.83M | 89.98%-889K | 24.09%-208K | -187.74%-446K | -19.42%-289K | -1,372.53%-9.54M | -1,268.98%-8.87M | -274K | -155K |
| Net income | 34.95%-2.62M | 69.71%-12.85M | 89.12%-3.17M | 38.52%-2.39M | 33.60%-3.27M | 11.07%-4.02M | -332.11%-42.43M | -645.06%-29.09M | -2.94%-3.89M | -602.45%-4.93M |
| Net income continuous Operations | 34.95%-2.62M | 69.71%-12.85M | 89.12%-3.17M | 38.52%-2.39M | 33.60%-3.27M | 11.07%-4.02M | -332.11%-42.43M | -645.06%-29.09M | -2.94%-3.89M | -602.45%-4.93M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 34.95%-2.62M | 69.71%-12.85M | 89.12%-3.17M | 38.52%-2.39M | 33.60%-3.27M | 11.07%-4.02M | -332.11%-42.43M | -645.06%-29.09M | -2.94%-3.89M | -602.45%-4.93M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 34.95%-2.62M | 69.71%-12.85M | 89.12%-3.17M | 38.52%-2.39M | 33.60%-3.27M | 11.07%-4.02M | -332.11%-42.43M | -645.06%-29.09M | -2.94%-3.89M | -602.45%-4.93M |
| Basic earnings per share | 55.56%-0.24 | 69.70%-1.73 | 89.01%-0.4297 | 37.51%-0.3249 | 34.85%-0.43 | 11.48%-0.54 | -252.47%-5.71 | -639.27%-3.91 | 3.70%-0.52 | -466.67%-0.66 |
| Diluted earnings per share | 55.56%-0.24 | 69.70%-1.73 | 89.01%-0.4297 | 37.51%-0.3249 | 34.85%-0.43 | 11.48%-0.54 | -252.47%-5.71 | -639.27%-3.91 | 3.70%-0.52 | -466.67%-0.66 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg